These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 29059259

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
    Akalin A, Colak O, Alatas O, Efe B.
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma.
    De Menis E, Da Rin G, Roiter I, Legovini P, Foscolo G, Conte N.
    Horm Res; 1992 Jul; 37(6):217-20. PubMed ID: 1292974
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hyperthyroidism and Hypothyroidism in Male Mice and Their Effects on Bone Mass, Bone Turnover, and the Wnt Inhibitors Sclerostin and Dickkopf-1.
    Tsourdi E, Rijntjes E, Köhrle J, Hofbauer LC, Rauner M.
    Endocrinology; 2015 Oct; 156(10):3517-27. PubMed ID: 26218891
    [Abstract] [Full Text] [Related]

  • 9. [The influence of hyperthyroidism and glucocorticosteroid treatment on bone metabolism in patients with Graves' disease and ophthalmopathy].
    Kaźmierczyk-Puchalska A, Kulig G, Krzyzanowska-Swiniarska B, Pilarska K.
    Endokrynol Pol; 2005 Oct; 56(3):259-64. PubMed ID: 16350719
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women.
    Gürlek A, Gedik O.
    Thyroid; 1999 Jun; 9(6):539-43. PubMed ID: 10411115
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study.
    Engler H, Oettli RE, Riesen WF.
    Clin Chim Acta; 1999 Nov; 289(1-2):159-72. PubMed ID: 10556662
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time.
    Olkawa M, Kushida K, Takahashi M, Ohishi T, Hoshino H, Suzuki M, Ogihara H, Ishigaki J, Inoue T.
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):171-6. PubMed ID: 10396358
    [Abstract] [Full Text] [Related]

  • 18. Wnt Inhibitors and Bone Mineral Density in Patients with Graves' Disease Treated with Antithyroid Drugs: A Preliminary Prospective Study.
    Mudri D, Kizivat T, Mihaljević I, Bilić Ćurčić I.
    Metabolites; 2022 Jul 29; 12(8):. PubMed ID: 36005583
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.